Publications
“Concentration-Independent Multivalent Targeting of Cancer Cells by Genetically Encoded Core-Crosslinked Elastin/Resilin-like Polypeptide Micelles”, Biomacromolecules, vol. 22, no. 10, pp. 4347 - 4356, 2021. ,
“Microphase Separation of Resilin-like and Elastin-like Diblock Copolypeptides in Concentrated Solutions”, Biomacromolecules, vol. 22, no. 9, pp. 3827 - 3838, 2021. ,
“Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates”, npj Breast Cancer, vol. 7, no. 1, 2021. ,
“Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test”, Science Advances, vol. 7, no. 26, p. eabg4901, 2021. ,
“Protein Phase Separation Arising from Intrinsic Disorder: First-Principles to Bespoke Applications”, The Journal of Physical Chemistry B, vol. 125, no. 25, pp. 6740 - 6759, 2021. ,
“Genetically Encoded Elastin‐Like Polypeptides for Drug Delivery”, Advanced Healthcare Materials, vol. 10, no. 13, p. 2100209, 2021. ,
“Modular complement assemblies for mitigating inflammatory conditions”, Proceedings of the National Academy of Sciences, vol. 118, no. 15, p. e2018627118, 2021. ,
“Nanoscopic Dynamics Dictate the Phase Separation Behavior of Intrinsically Disordered Proteins”, Biomacromolecules, vol. 22, no. 2, pp. 1015 - 1025, 2021. ,
Methods in Molecular BiologyBiomedical Engineering TechnologiesSmartphone Enabled Point-of-Care Detection of Serum Biomarkers, vol. 2393. New York, NY: Springer US, 2021, pp. 343 - 365. ,
“De novo engineering of intracellular condensates using artificial disordered proteins”, Nature Chemistry, 2020. ,
“A Quantitative Study of the Interaction of Multivalent Ligand-Modified Nanoparticles with Breast Cancer Cells with Tunable Receptor Density”, ACS Nano, 2020. ,
“Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia”, Science Advances, vol. 6, no. 35, p. eaaz9890, 2020. ,
“Elastin-Like Polypeptides for Biomedical Applications”, Annual Review of Biomedical Engineering, vol. 22, no. 1, pp. 343 - 369, 2020. ,
“Engineering the Architecture of Elastin‐Like Polypeptides: From Unimers to Hierarchical Self‐Assembly”, Advanced Therapeutics, vol. 3, no. 3, 2020. ,
“Recent trends in protein and peptide-based biomaterials for advanced drug delivery.”, Adv Drug Deliv Rev, vol. 156, pp. 133-187, 2020. ,
“In Pursuit of Zero 2.0: Recent Developments in Nonfouling Polymer Brushes for Immunoassays”, Advanced Materials, vol. 32, no. 2, p. 1903285, 2020. ,
“Rapid capture of biomolecules from blood via stimuli-responsive elastomeric particles for acoustofluidic separation”, The Analyst, vol. 145, no. 24, pp. 8087 - 8096, 2020. ,
“Recombinant Fusion of Glucagon‐Like Peptide‐1 and an Albumin Binding Domain Provides Glycemic Control for a Week in Diabetic Mice”, Advanced Therapeutics, vol. 3, no. 10, p. 2000073, 2020. ,
“Complex microparticle architectures from stimuli-responsive intrinsically disordered proteins”, Nature Communications, vol. 11, no. 1342, 2020. ,
“Heuristics for the Optimal Presentation of Bioactive Peptides on Polypeptide Micelles”, Nano Letters, vol. 19, no. 11, pp. 7977 - 7987, 2019. ,
“Engineered Ribonucleoprotein Granules Inhibit Translation in Protocells”, Molecular Cell, 2019. ,
“Molecular and Materials Engineering for Delivery of Peptide Drugs to Treat Type 2 Diabetes”, Advanced Healthcare Materials, no. 1801509, p. 1801509, 2019. ,
“Conjugate of Doxorubicin to Albumin‐Binding Peptide Outperforms Aldoxorubicin”, Small, vol. 15, no. 12, p. 1804452, 2019. ,
“Genetically Encoded Cholesterol-Modified Polypeptides”, Journal of the American Chemical Society, vol. 141, no. 2, pp. 945 - 951, 2019. ,
“Molecular and Materials Engineering for Delivery of Peptide Drugs to Treat Type 2 Diabetes.”, Adv Healthc Mater, vol. 8, no. 12, p. e1801509, 2019. ,